As of Mar 16
| -0.02 / -0.54%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 27.00, with a high estimate of 27.00 and a low estimate of 27.00. The median estimate represents a +639.73% increase from the last price of 3.65.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.